adss

1 day ago

Israeli biopharma company Teva Pharmaceutical Industries Limited (TEVA) is set to replace its American Depository Shares (ADSs) with the direct listing of its ordinary shares on the NYSE. The shares will start trading on Sept. 14 after the ADSs stop trading, with the ADS-holders receiving a one-for-one exchange. The move highlights the company's focus on United States market growth, aiming to broaden its shareholder base and optimize its cost of capital. This also opens up the potential for the stock to be included in major indices, potentially bringing greater visibility and institutional investors' attention.
We take a closer look at Teva Pharmaceutical before that happens.
CoreWeave Just Scored a Leidos Partnership. What That Means for CRWV Stock Here.
Palantir Is Set to Deliver Strong Q2. ****** ysts See 60% Upside Potential for PLTR Stock.
Earnings, PMI and Other Key Things to Watch this Week

#adss

riceyalwavdu01

27 days ago

SpaceX (SPCX) was undoubtedly the hottest initial public offering in 2026 so far. However, in terms of investor anticipation and the potential to create value, SK Hynix is not far behind.
As one of the largest memory semiconductor companies, SK Hynix has announced plans for offering 177.9 million American Depositary Shares (ADSs). The trading is expected to begin on July 10 and the company will be mopping up $28 billion from the offering. Investors can expect some fireworks on the listing with the company growing at a robust pace.
Broadcom's Largest AI Customer Is Fleeing to MediaTek. AVGO Stock Is Still a Buy.
Mark Cuban Asks What If You Didn't Need Health Insurance — And Hospitals Just Treated You, Then Took 10% of Your Pay?
Nasdaq Futures Plunge as Samsung Sparks Chip Selloff